ATE157870T1 - Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma - Google Patents

Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma

Info

Publication number
ATE157870T1
ATE157870T1 AT95100934T AT95100934T ATE157870T1 AT E157870 T1 ATE157870 T1 AT E157870T1 AT 95100934 T AT95100934 T AT 95100934T AT 95100934 T AT95100934 T AT 95100934T AT E157870 T1 ATE157870 T1 AT E157870T1
Authority
AT
Austria
Prior art keywords
optionally substituted
hydrogen
treatment
ophthalmic composition
benzoxathiepine
Prior art date
Application number
AT95100934T
Other languages
English (en)
Inventor
Takahiro Ogawa
Takaaki Deguchi
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE157870T1 publication Critical patent/ATE157870T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95100934T 1994-01-27 1995-01-25 Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma ATE157870T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP747094 1994-01-27

Publications (1)

Publication Number Publication Date
ATE157870T1 true ATE157870T1 (de) 1997-09-15

Family

ID=11666688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95100934T ATE157870T1 (de) 1994-01-27 1995-01-25 Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma

Country Status (9)

Country Link
US (1) US5538974A (de)
EP (1) EP0667156B1 (de)
KR (1) KR950032169A (de)
CN (1) CN1116928A (de)
AT (1) ATE157870T1 (de)
CA (1) CA2141176A1 (de)
DE (1) DE69500660T2 (de)
ES (1) ES2106573T3 (de)
TW (1) TW316235B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) * 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
AU755119B2 (en) 1998-09-18 2002-12-05 Alcon Laboratories, Inc. Serotonergic 5HT2 agonists for treating glaucoma
DE60117247D1 (de) * 2000-03-31 2006-04-20 Purdue Research Foundation West Lafayette Phosphoramidat-prodrugs
FR2822467B1 (fr) * 2001-03-22 2003-12-12 Pf Medicament Derives benzoxathiepines et leur utilisation comme medicaments
JP2005511764A (ja) * 2001-12-14 2005-04-28 アルコン,インコーポレイテッド 緑内障の処置のためのアミノアルキルベンゾフラン−5−オール化合物
TW593302B (en) * 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
DK1534391T3 (da) * 2002-07-19 2007-06-11 Biovitrum Ab Nye piperazinyl-pyrazinonderivater til behandling af 5-HT2A-recptor-relaterede forstyrrelser
JP2006501245A (ja) * 2002-08-30 2006-01-12 アルコン,インコーポレイテッド 置換された5−クロマン−5−イル−エチルアミン化合物および緑内障の治療のためのその使用
BR0316775A (pt) * 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
US20060286173A1 (en) * 2003-08-20 2006-12-21 Kazuhito Yamada Drug delivery system for sub-tenon s capsule adminstration of fine grains
US7476687B2 (en) * 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
AR046890A1 (es) * 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
US7129257B1 (en) * 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US20050276867A1 (en) * 2004-06-09 2005-12-15 Allergan, Inc. Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
WO2006062839A1 (en) * 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
TW200744567A (en) * 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
WO2007149728A2 (en) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
EP2095713A1 (de) * 2006-10-20 2009-09-02 Limited Liability Company "Mitotechnology" Zusammensetzung für die regeneration und stimulation des wachstums von pflanzen und für die anpassung von pflanzen an unterschiedliche stressfaktoren
EA200900582A1 (ru) * 2006-10-20 2009-08-28 Общество С Ограниченной Ответственностью "Митотехнология" Фармацевтические композиции для профилактики и лечения глазных патологий
EP2145623A4 (de) * 2007-01-29 2010-10-27 Ltd Liability Company Mitotech Pharmazeutische und kosmetische zusammensetzungen zur beschleunigten heilung von wunden und anderen oberflächenschäden
WO2008094062A1 (en) 2007-01-29 2008-08-07 Limited Liability Company 'mitotechnology' Pharmaceutical compositions useful for preventing and treating oncological diseases
EA016723B1 (ru) * 2007-02-27 2012-07-30 Дели Инститьют Оф Фармасьютикал Сайнсиз Энд Рисерч (Дипсар) Синергетическая травяная композиция, применяемая при глаукоме, и способ ее получения
WO2008127138A1 (fr) * 2007-04-11 2008-10-23 Limited Liability Company 'mitotechnology' Composition visant à ralentir le vieillissement et à allonger la durée de vie de l'organisme et utilisation de cette composition
US8518915B2 (en) 2007-06-29 2013-08-27 Mitotech Sa Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases
US9308214B2 (en) 2008-11-12 2016-04-12 Mitotech S.A. Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations
EA025414B1 (ru) * 2009-06-10 2016-12-30 Общество С Ограниченной Ответственностью "Митотех" Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии
MX2012005356A (es) 2009-11-13 2013-01-29 Obschestvo S Ogranichennoi Otvetstvennostyu Mitotekh Substancias farmaceuticas basadas en antioxidantes dirigidos a mitocondria.
CN103260466B (zh) 2010-12-20 2016-08-17 高露洁-棕榄公司 含有亲水性活性物质、疏水性结构化剂和油载体的明胶包囊的口腔护理组合物
ES2704064T3 (es) 2011-06-03 2019-03-14 Mitotech Sa Formulaciones orales de antioxidantes dirigidos mitocondrialmente y su preparación y uso
CN112439071B (zh) * 2019-09-04 2022-05-20 武汉科福新药有限责任公司 透皮促渗组合物及其在噻吗洛尔制剂中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166779B1 (da) * 1983-12-14 1993-07-12 Takeda Chemical Industries Ltd 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse
EP0229467A1 (de) * 1985-12-10 1987-07-22 Takeda Chemical Industries, Ltd. 1,5-Benzoxathiepin-Derivate, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
ES2106573T3 (es) 1997-11-01
DE69500660D1 (de) 1997-10-16
DE69500660T2 (de) 1998-02-26
CA2141176A1 (en) 1995-07-28
CN1116928A (zh) 1996-02-21
EP0667156B1 (de) 1997-09-10
EP0667156A1 (de) 1995-08-16
KR950032169A (ko) 1995-12-20
TW316235B (de) 1997-09-21
US5538974A (en) 1996-07-23

Similar Documents

Publication Publication Date Title
DE69500660D1 (de) Ophthalmische Zusammensetzung enthaltend ein 1,5-Benzoxathiepin-Derivat zur Behandlung von Glaukoma
DE19680619D2 (de) Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
GB9113166D0 (en) Heterocyclene derivatives
ATE112762T1 (de) Herstellung und verwendung von n-jodopropargyl- oxycarbonylaminosäure-estern als antimicrobielle mittel.
ATE161723T1 (de) Arzneimittel zur verwendung bei der behandlung von parkinsonismus
DE69406323D1 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE69008542D1 (de) Chinolinderivate, ihre herstellung und verwendung.
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DE69017779D1 (de) Hydroxylamin-derivate.
ATE196080T1 (de) Verwendung von diphenylethanderivaten zur herstellung eines arzneimittels zur behandlung von glaukom
DE69611502D1 (de) (Oxo-1-Alkyl)amino-2-desoxy-2-glucopyranosid von Dihydroxy-2,3-propyl, Verfahren zur Herstellung und ihre Verwendungen
EA199800176A1 (ru) Применение производных сульфаминовой кислоты , ацилсульфонамидов или сульфонилкарбаматов для получения лекарственных средств, снижающих уровень липопротеинов
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
DE69706355D1 (de) Alkylendiamin-Derivate als Arzneimittel zur Behandlung von Geschwüren und Hemmung von Helicobacter pylori
EP0635011A1 (de) Hydrazid-derivate von 3,4-dihydro-2h-1-benzopyranen.
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE79752T1 (de) Verwendung von chromanderivaten zur herstellung eines medikamentes zur behandlung von depressiven zustaenden.
ATE122892T1 (de) Zusammensetzung gegen katarakt.
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
ATE120461T1 (de) Imidazolylpropylguanidinderivat, verfahren zu seiner herstellung und diese verbindung enthaltende arzneimittel.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE157874T1 (de) Mittel zur verbesserung der peripheren durchblutung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties